EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Amyloid-β predominant Alzheimer’s disease neuropathologic change

Gabor G Kovacs iD, Yuriko Katsumata iD, Xian Wu, Khine Zin Aung, David W Fardo, Shelley L Forrest, Alzheimer's Disease Genetics Consortium, Peter T Nelson

Brain · 03.02.2025 · 148 (2) · 401-407

DOI: 10.1093/brain/awae325 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain, online erschienen am 17.10.2024. Verfasst von Gabor G Kovacs und 7 weiteren Autor:innen. Beteiligte Einrichtung: Tanz Centre for Research in Neurodegenerative Disease and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario…. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, Brain. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NCRR NIH HHS, NIMH NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Different subsets of Alzheimer’s disease neuropathologic change (ADNC), including the intriguing set of individuals with severe/widespread amyloid-β (Aβ) plaques but no/mild tau tangles [Aβ-predominant (AP)-ADNC], may have distinct genetic and clinical features. Analysing National Alzheimer’s Coordinating Center data, we stratified 1187 participants into AP-ADNC (n = 95), low Braak primary age-related tauopathy (PART; n = 185), typical-ADNC (n = 832) and high-Braak PART (n = 75). AP-ADNC differed in some clinical features and genetic polymorphisms in the APOE, SNX1, WNT3/MAPT and IGH genes. We conclude that AP-ADNC differs from classical ADNC with implications for in vivo studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseAmyloid beta-PeptidesBrainHumansFemaleMaleAgedAged, 80 and overtau ProteinsPlaque, AmyloidNeurofibrillary TanglesApolipoproteins ETauopathiesSorting NexinsMiddle Aged

Stichwörter der Autor:innen

ADGCNACCamyloid-βbiomarkerdiffuse plaques

Substanzen

Amyloid beta-Peptidestau ProteinsApolipoproteins ESorting NexinsMAPT protein, human

Autor:innen und Institutionen

  • Tanz Centre for Research in Neurodegenerative Disease and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario M5T 0S8, Canada.
  • Laboratory Medicine Program and Krembil Brain Institute, University Health Network, Toronto, Ontario M5G 2C4, Canada.
  • Department of Biostatistics, University of Kentucky, Lexington, KY 40536-0679, USA.
  • Sanders-Brown Center on Aging, University of Kentucky, Lexington, KY 40536, USA.
  • Department of Pathology, Division of Neuropathology, University of Kentucky, Lexington, KY 40536-0679, USA.

ORCID-Profile: Gabor G Kovacs, Yuriko Katsumata

Förderung

  • NIA NIH HHS
  • NCRR NIH HHS
  • NIMH NIH HHS
  • NHGRI NIH HHS
  • NINDS NIH HHS
  • NCI NIH HHS
  • NIH HHS
  • Wellcome Trust

Zitieren

APA

Kovacs, G. G., Katsumata, Y., Wu, X., Aung, K. Z., Fardo, D. W., Forrest, S. L., Alzheimer's Disease Genetics Consortium, & Nelson, P. T. (2025). Amyloid-β predominant Alzheimer’s disease neuropathologic change. Brain, 148(2), 401-407. https://doi.org/10.1093/brain/awae325

Vancouver

Kovacs GG, Katsumata Y, Wu X, Aung KZ, Fardo DW, Forrest SL, et al. Amyloid-β predominant Alzheimer’s disease neuropathologic change. Brain. 2025;148(2):401-407. doi:10.1093/brain/awae325

BibTeX
@article{Kovacs2025,
  author = {Kovacs, Gabor G and Katsumata, Yuriko and Wu, Xian and Aung, Khine Zin and Fardo, David W and Forrest, Shelley L and Alzheimer's Disease Genetics Consortium, Alzheimer's Disease Genetics Consortium and Nelson, Peter T},
  title = {Amyloid-β predominant Alzheimer’s disease neuropathologic change},
  journal = {Brain},
  year = {2025},
  volume = {148},
  number = {2},
  pages = {401--407},
  doi = {10.1093/brain/awae325}
}
Kostenlos starten →